{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:27:32Z","timestamp":1794014852559,"version":"4.8.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41581-025-01029-x","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T14:49:45Z","timestamp":1764341385000},"page":"215-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Natural killer cells in kidney immune surveillance, injury and fibrosis"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-2810","authenticated-orcid":false,"given":"Amir","family":"Horowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-6913","authenticated-orcid":false,"given":"Peter","family":"Heeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231222","volume":"221","author":"LL Lanier","year":"2024","unstructured":"Lanier, L. L. Five decades of natural killer cell discovery. J. Exp. Med. 221, e20231222 (2024).","journal-title":"J. Exp. Med."},{"key":"1029_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44\u201349 (2011).","journal-title":"Science"},{"key":"1029_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2015.9","volume":"16","author":"A Cerwenka","year":"2016","unstructured":"Cerwenka, A. & Lanier, L. L. Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16, 112\u2013123 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR4","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.4049\/jimmunol.1301889","volume":"192","author":"P Carrega","year":"2014","unstructured":"Carrega, P. et al. CD56brightperforinlow noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. J. Immunol. 192, 3805\u20133815 (2014).","journal-title":"J. Immunol."},{"key":"1029_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/imr.12600","volume":"280","author":"DH Raulet","year":"2017","unstructured":"Raulet, D. H., Marcus, A. & Coscoy, L. Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells. Immunol. Rev. 280, 93\u2013101 (2017).","journal-title":"Immunol. Rev."},{"key":"1029_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag1672","volume":"1","author":"A Horowitz","year":"2016","unstructured":"Horowitz, A. et al. Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci. Immunol. 1, eaag1672 (2016).","journal-title":"Sci. Immunol."},{"key":"1029_CR7","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.4049\/jimmunol.1401821","volume":"193","author":"DM Strauss-Albee","year":"2014","unstructured":"Strauss-Albee, D. M., Horowitz, A., Parham, P. & Blish, C. A. Coordinated regulation of NK receptor expression in the maturing human immune system. J. Immunol. 193, 4871\u20134879 (2014).","journal-title":"J. Immunol."},{"key":"1029_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006702","volume":"5","author":"A Horowitz","year":"2013","unstructured":"Horowitz, A. et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5, 208ra145 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1029_CR9","doi-asserted-by":"publisher","unstructured":"Hegewisch-Solloa, E. et al. Mapping human natural killer cell development in pediatric tonsil by imaging mass cytometry and high-resolution microscopy. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.09.05.556371 (2023).","DOI":"10.1101\/2023.09.05.556371"},{"key":"1029_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","volume":"214","author":"AG Freud","year":"2006","unstructured":"Freud, A. G. & Caligiuri, M. A. Human natural killer cell development. Immunol. Rev. 214, 56\u201372 (2006).","journal-title":"Immunol. Rev."},{"key":"1029_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1084\/jem.20052507","volume":"203","author":"AG Freud","year":"2006","unstructured":"Freud, A. G. et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203, 1033\u20131043 (2006).","journal-title":"J. Exp. Med."},{"key":"1029_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nri.2016.34","volume":"16","author":"NK Bjorkstrom","year":"2016","unstructured":"Bjorkstrom, N. K., Ljunggren, H. G. & Michaelsson, J. Emerging insights into natural killer cells in human peripheral tissues. Nat. Rev. Immunol. 16, 310\u2013320 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41590-024-01884-z","volume":"25","author":"H Netskar","year":"2024","unstructured":"Netskar, H. et al. Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping. Nat. Immunol. 25, 1445\u20131459 (2024).","journal-title":"Nat. Immunol."},{"key":"1029_CR14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet, L. et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat. Immunol. 25, 1474\u20131488 (2024).","journal-title":"Nat. Immunol."},{"key":"1029_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","volume":"25","author":"N Anfossi","year":"2006","unstructured":"Anfossi, N. et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331\u2013342 (2006).","journal-title":"Immunity"},{"key":"1029_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1600-065X.2006.00458.x","volume":"214","author":"WM Yokoyama","year":"2006","unstructured":"Yokoyama, W. M. & Kim, S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 214, 143\u2013154 (2006).","journal-title":"Immunol. Rev."},{"key":"1029_CR17","doi-asserted-by":"publisher","first-page":"10332","DOI":"10.1073\/pnas.88.22.10332","volume":"88","author":"P Hoglund","year":"1991","unstructured":"Hoglund, P. et al. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc. Natl Acad. Sci. USA 88, 10332\u201310336 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1029_CR18","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1182\/blood-2008-05-156836","volume":"113","author":"P Brodin","year":"2009","unstructured":"Brodin, P., Lakshmikanth, T., Johansson, S., Karre, K. & Hoglund, P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113, 2434\u20132441 (2009).","journal-title":"Blood"},{"key":"1029_CR19","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1084\/jem.185.12.2079","volume":"185","author":"W Held","year":"1997","unstructured":"Held, W. & Raulet, D. H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. Med. 185, 2079\u20132088 (1997).","journal-title":"J. Exp. Med."},{"key":"1029_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev-immunol-042617-053149","volume":"36","author":"P Parham","year":"2018","unstructured":"Parham, P. & Guethlein, L. A. Genetics of natural killer cells in human health, disease, and survival. Annu. Rev. Immunol. 36, 519\u2013548 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"1029_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri3370","volume":"13","author":"P Parham","year":"2013","unstructured":"Parham, P. & Moffett, A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13, 133\u2013144 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri1570","volume":"5","author":"P Parham","year":"2005","unstructured":"Parham, P. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5, 201\u2013214 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature03847","volume":"436","author":"S Kim","year":"2005","unstructured":"Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709\u2013713 (2005).","journal-title":"Nature"},{"key":"1029_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009131","volume":"17","author":"M Migdal","year":"2021","unstructured":"Migdal, M., Ruan, D. F., Forrest, W. F., Horowitz, A. & Hammer, C. MiDAS-meaningful immunogenetic data at scale. PLoS Comput. Biol. 17, e1009131 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"1029_CR25","first-page":"362","volume":"136","author":"EW Petersdorf","year":"2020","unstructured":"Petersdorf, E. W. et al. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation. Blood 136, 362\u2013369 (2020).","journal-title":"Blood"},{"key":"1029_CR26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2017-08-752170","volume":"131","author":"S Cooley","year":"2018","unstructured":"Cooley, S., Parham, P. & Miller, J. S. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. Blood 131, 1053\u20131062 (2018).","journal-title":"Blood"},{"key":"1029_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ng2035","volume":"39","author":"MP Martin","year":"2007","unstructured":"Martin, M. P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733\u2013740 (2007).","journal-title":"Nat. Genet."},{"key":"1029_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature10237","volume":"476","author":"G Alter","year":"2011","unstructured":"Alter, G. et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476, 96\u2013100 (2011).","journal-title":"Nature"},{"key":"1029_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.1097670","volume":"305","author":"SI Khakoo","year":"2004","unstructured":"Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872\u2013874 (2004).","journal-title":"Science"},{"key":"1029_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aam8825","volume":"359","author":"V Ramsuran","year":"2018","unstructured":"Ramsuran, V. et al. Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science 359, 86\u201390 (2018).","journal-title":"Science"},{"key":"1029_CR31","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/bloodadvances.2019000699","volume":"4","author":"SL Smith","year":"2020","unstructured":"Smith, S. L. et al. Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing. Blood Adv. 4, 1388\u20131406 (2020).","journal-title":"Blood Adv."},{"key":"1029_CR32","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","volume":"116","author":"L Moretta","year":"2010","unstructured":"Moretta, L. Dissecting CD56dim human NK cells. Blood 116, 3689\u20133691 (2010).","journal-title":"Blood"},{"key":"1029_CR33","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel, T. et al. Human CD56bright NK cells: an update. J. Immunol. 196, 2923\u20132931 (2016).","journal-title":"J. Immunol."},{"key":"1029_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli, A. et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126, 458\u2013465 (2009).","journal-title":"Immunology"},{"key":"1029_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00422","volume":"4","author":"CM Nielsen","year":"2013","unstructured":"Nielsen, C. M., White, M. J., Goodier, M. R. & Riley, E. M. Functional significance of CD57 expression on human NK cells and relevance to disease. Front. Immunol. 4, 422 (2013).","journal-title":"Front. Immunol."},{"key":"1029_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","volume":"65","author":"H Kared","year":"2016","unstructured":"Kared, H., Martelli, S., Ng, T. P., Pender, S. L. & Larbi, A. CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol. Immunother. 65, 441\u2013452 (2016).","journal-title":"Cancer Immunol. Immunother."},{"key":"1029_CR37","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2020.02.029","volume":"180","author":"A Crinier","year":"2020","unstructured":"Crinier, A., Narni-Mancinelli, E., Ugolini, S. & Vivier, E. SnapShot: natural killer cells. Cell 180, 1280\u20131280.e1 (2020).","journal-title":"Cell"},{"key":"1029_CR38","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.4049\/jimmunol.176.12.7511","volume":"176","author":"JR Carlyle","year":"2006","unstructured":"Carlyle, J. R. et al. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J. Immunol. 176, 7511\u20137524 (2006).","journal-title":"J. Immunol."},{"key":"1029_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00262","volume":"7","author":"JE Melsen","year":"2016","unstructured":"Melsen, J. E., Lugthart, G., Lankester, A. C. & Schilham, M. W. Human circulating and tissue-resident CD56bright natural killer cell populations. Front. Immunol. 7, 262 (2016).","journal-title":"Front. Immunol."},{"key":"1029_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00455-6","volume":"6","author":"K Sun","year":"2021","unstructured":"Sun, K., Li, Y. Y. & Jin, J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal Transduct. Target. Ther. 6, 79 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1029_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657\u2013667 (2008).","journal-title":"Cell"},{"key":"1029_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00019","volume":"7","author":"F Fasbender","year":"2016","unstructured":"Fasbender, F., Widera, A., Hengstler, J. G. & Watzl, C. Natural killer cells and liver fibrosis. Front. Immunol. 7, 19 (2016).","journal-title":"Front. Immunol."},{"key":"1029_CR43","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.4049\/jimmunol.1701461","volume":"200","author":"V Zaiatz-Bittencourt","year":"2018","unstructured":"Zaiatz-Bittencourt, V., Finlay, D. K. & Gardiner, C. M. Canonical TGF-\u03b2 signaling pathway represses human NK cell metabolism. J. Immunol. 200, 3934\u20133941 (2018).","journal-title":"J. Immunol."},{"key":"1029_CR44","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ni.3838","volume":"18","author":"N Assmann","year":"2017","unstructured":"Assmann, N. et al. Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat. Immunol. 18, 1197\u20131206 (2017).","journal-title":"Nat. Immunol."},{"key":"1029_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04719-2","volume":"9","author":"RM Loftus","year":"2018","unstructured":"Loftus, R. M. et al. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat. Commun. 9, 2341 (2018).","journal-title":"Nat. Commun."},{"key":"1029_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4049\/jimmunol.2200851","volume":"211","author":"JR Lozada","year":"2023","unstructured":"Lozada, J. R., Zhang, B., Miller, J. S. & Cichocki, F. NK cells from human cytomegalovirus-seropositive individuals have a distinct metabolic profile that correlates with elevated mTOR signaling. J. Immunol. 211, 539\u2013550 (2023).","journal-title":"J. Immunol."},{"key":"1029_CR47","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang, F. et al. A pan-cancer single-cell panorama of human natural killer cells. Cell 186, 4235\u20134251.e20 (2023).","journal-title":"Cell"},{"key":"1029_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/IN9.0000000000000020","volume":"5","author":"H Sohn","year":"2023","unstructured":"Sohn, H. & Cooper, M. A. Metabolic regulation of NK cell function: implications for immunotherapy. Immunometabolism 5, e00020 (2023).","journal-title":"Immunometabolism"},{"key":"1029_CR49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nri956","volume":"2","author":"A Moretta","year":"2002","unstructured":"Moretta, A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2, 957\u2013964 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR50","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nri3919","volume":"15","author":"B Jabri","year":"2015","unstructured":"Jabri, B. & Abadie, V. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat. Rev. Immunol. 15, 771\u2013783 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2057","volume":"7","author":"KC Newman","year":"2007","unstructured":"Newman, K. C. & Riley, E. M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7, 279\u2013291 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR52","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","volume":"97","author":"MA Cooper","year":"2001","unstructured":"Cooper, M. A. et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 97, 3146\u20133151 (2001).","journal-title":"Blood"},{"key":"1029_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper, M. A., Fehniger, T. A. & Caligiuri, M. A. The biology of human natural killer-cell subsets. Trends Immunol. 22, 633\u2013640 (2001).","journal-title":"Trends Immunol."},{"key":"1029_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771\u2013780 (2000).","journal-title":"J. Exp. Med."},{"key":"1029_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","volume":"17","author":"TA Waldmann","year":"1999","unstructured":"Waldmann, T. A. & Tagaya, Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17, 19\u201349 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"1029_CR56","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nri2154","volume":"7","author":"ND Huntington","year":"2007","unstructured":"Huntington, N. D., Vosshenrich, C. A. & Di Santo, J. P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7, 703\u2013714 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR57","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","volume":"43","author":"S Ma","year":"2022","unstructured":"Ma, S., Caligiuri, M. A. & Yu, J. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy. Trends Immunol. 43, 833\u2013847 (2022).","journal-title":"Trends Immunol."},{"key":"1029_CR58","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.4049\/jimmunol.2100055","volume":"207","author":"M Ataya","year":"2021","unstructured":"Ataya, M. et al. Long-term evolution of the adaptive NKG2C+ NK cell response to cytomegalovirus infection in kidney transplantation: an insight on the diversity of host\u2013pathogen interaction. J. Immunol. 207, 1882\u20131890 (2021).","journal-title":"J. Immunol."},{"key":"1029_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mad.2016.06.010","volume":"158","author":"M Lopez-Botet","year":"2016","unstructured":"Lopez-Botet, M. et al. Development of the adaptive NK cell response to human cytomegalovirus in the context of aging. Mech. Ageing Dev. 158, 23\u201326 (2016).","journal-title":"Mech. Ageing Dev."},{"key":"1029_CR60","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","volume":"107","author":"M Guma","year":"2006","unstructured":"Guma, M. et al. Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107, 3624\u20133631 (2006).","journal-title":"Blood"},{"key":"1029_CR61","first-page":"207","volume":"298","author":"M Guma","year":"2006","unstructured":"Guma, M., Angulo, A. & Lopez-Botet, M. NK cell receptors involved in the response to human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 298, 207\u2013223 (2006).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1029_CR62","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","volume":"121","author":"V Beziat","year":"2013","unstructured":"Beziat, V. et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121, 2678\u20132688 (2013).","journal-title":"Blood"},{"key":"1029_CR63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000445320","volume":"8","author":"Z Djaoud","year":"2016","unstructured":"Djaoud, Z. et al. Cytomegalovirus-infected primary endothelial cells trigger NKG2C+ natural killer cells. J. Innate Immun. 8, 374\u2013385 (2016).","journal-title":"J. Innate Immun."},{"key":"1029_CR64","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1093\/emboj\/18.15.4250","volume":"18","author":"M Vales-Gomez","year":"1999","unstructured":"Vales-Gomez, M., Reyburn, H. T., Erskine, R. A., Lopez-Botet, M. & Strominger, J. L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94\/NKG2-A and the activating receptor CD94\/NKG2-C to HLA-E. EMBO J. 18, 4250\u20134260 (1999).","journal-title":"EMBO J."},{"key":"1029_CR65","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41590-018-0163-6","volume":"19","author":"Q Hammer","year":"2018","unstructured":"Hammer, Q., Ruckert, T. & Romagnani, C. Natural killer cell specificity for viral infections. Nat. Immunol. 19, 800\u2013808 (2018).","journal-title":"Nat. Immunol."},{"key":"1029_CR66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","volume":"19","author":"Q Hammer","year":"2018","unstructured":"Hammer, Q. et al. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat. Immunol. 19, 453\u2013463 (2018).","journal-title":"Nat. Immunol."},{"key":"1029_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","volume":"42","author":"H Schlums","year":"2015","unstructured":"Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443\u2013456 (2015).","journal-title":"Immunity"},{"key":"1029_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/eji.201141826","volume":"42","author":"V Beziat","year":"2012","unstructured":"Beziat, V. et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42, 447\u2013457 (2012).","journal-title":"Eur. J. Immunol."},{"key":"1029_CR69","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1086\/504719","volume":"194","author":"M Guma","year":"2006","unstructured":"Guma, M. et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94\/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194, 38\u201341 (2006).","journal-title":"J. Infect. Dis."},{"key":"1029_CR70","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","volume":"42","author":"J Lee","year":"2015","unstructured":"Lee, J. et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 42, 431\u2013442 (2015).","journal-title":"Immunity"},{"key":"1029_CR71","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"1029_CR72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.coi.2018.11.003","volume":"56","author":"SD Scoville","year":"2019","unstructured":"Scoville, S. D., Freud, A. G. & Caligiuri, M. A. Cellular pathways in the development of human and murine innate lymphoid cells. Curr. Opin. Immunol. 56, 100\u2013106 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"1029_CR73","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","volume":"47","author":"AG Freud","year":"2017","unstructured":"Freud, A. G., Mundy-Bosse, B. L., Yu, J. & Caligiuri, M. A. The broad spectrum of human natural killer cell diversity. Immunity 47, 820\u2013833 (2017).","journal-title":"Immunity"},{"key":"1029_CR74","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","volume":"20","author":"SM Bal","year":"2020","unstructured":"Bal, S. M., Golebski, K. & Spits, H. Plasticity of innate lymphoid cell subsets. Nat. Rev. Immunol. 20, 552\u2013565 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.ai.2019.11.002","volume":"145","author":"J Zhou","year":"2020","unstructured":"Zhou, J., Tian, Z. & Peng, H. Tissue-resident NK cells and other innate lymphoid cells. Adv. Immunol. 145, 37\u201353 (2020).","journal-title":"Adv. Immunol."},{"key":"1029_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00587","volume":"10","author":"JE Turner","year":"2019","unstructured":"Turner, J. E., Rickassel, C., Healy, H. & Kassianos, A. J. Natural killer cells in kidney health and disease. Front. Immunol. 10, 587 (2019).","journal-title":"Front. Immunol."},{"key":"1029_CR77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1681\/ASN.2017060599","volume":"29","author":"JE Turner","year":"2018","unstructured":"Turner, J. E., Becker, M., Mittrucker, H. W. & Panzer, U. Tissue-resident lymphocytes in the kidney. J. Am. Soc. Nephrol. 29, 389\u2013399 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR78","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.4049\/jimmunol.1500651","volume":"195","author":"F Victorino","year":"2015","unstructured":"Victorino, F. et al. Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by anti-asialo-GM1 antibody. J. Immunol. 195, 4973\u20134985 (2015).","journal-title":"J. Immunol."},{"key":"1029_CR79","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/TP.0000000000001586","volume":"101","author":"MD Parkes","year":"2017","unstructured":"Parkes, M. D., Halloran, P. F. & Hidalgo, L. G. Evidence for CD16a-mediated NK cell stimulation in antibody-mediated kidney transplant rejection. Transplantation 101, e102\u2013e111 (2017).","journal-title":"Transplantation"},{"key":"1029_CR80","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.chom.2016.04.005","volume":"19","author":"R Apps","year":"2016","unstructured":"Apps, R. et al. HIV-1 Vpu mediates HLA-C downregulation. Cell Host Microbe 19, 686\u2013695 (2016).","journal-title":"Cell Host Microbe"},{"key":"1029_CR81","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01633-17","volume":"92","author":"Z Ende","year":"2018","unstructured":"Ende, Z. et al. HLA class I downregulation by HIV-1 variants from subtype C transmission pairs. J. Virol. 92, e01633-17 (2018).","journal-title":"J. Virol."},{"key":"1029_CR82","first-page":"91","volume":"4","author":"A Lin","year":"2007","unstructured":"Lin, A., Xu, H. & Yan, W. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell Mol. Immunol. 4, 91\u201398 (2007).","journal-title":"Cell Mol. Immunol."},{"key":"1029_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coi.2018.03.006","volume":"51","author":"N Aptsiauri","year":"2018","unstructured":"Aptsiauri, N., Ruiz-Cabello, F. & Garrido, F. The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses. Curr. Opin. Immunol. 51, 123\u2013132 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"1029_CR84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104504118","volume":"118","author":"M Fangazio","year":"2021","unstructured":"Fangazio, M. et al. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 118, e2104504118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1029_CR85","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41588-024-01883-8","volume":"56","author":"C Puttick","year":"2024","unstructured":"Puttick, C. et al. MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nat. Genet. 56, 2121\u20132131 (2024).","journal-title":"Nat. Genet."},{"key":"1029_CR86","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","volume":"171","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell 171, 1259\u20131271.e11 (2017).","journal-title":"Cell"},{"key":"1029_CR87","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","volume":"92","author":"BMP Law","year":"2017","unstructured":"Law, B. M. P. et al. Interferon-\u03b3 production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int. 92, 79\u201388 (2017).","journal-title":"Kidney Int."},{"key":"1029_CR88","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3892\/ijmm.2015.2317","volume":"36","author":"H Song","year":"2015","unstructured":"Song, H. et al. Transforming growth factor-\u03b21 regulates human renal proximal tubular epithelial cell susceptibility to natural killer cells via modulation of the NKG2D ligands. Int. J. Mol. Med. 36, 1180\u20131188 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"1029_CR89","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1172\/JCI0214574","volume":"109","author":"M Shinozaki","year":"2002","unstructured":"Shinozaki, M. et al. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J. Clin. Invest. 109, 951\u2013960 (2002).","journal-title":"J. Clin. Invest."},{"key":"1029_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1521086","volume":"16","author":"S Maddineni","year":"2025","unstructured":"Maddineni, S. et al. An intraepithelial ILC1-like natural killer cell subset produces IL-13. Front. Immunol. 16, 1521086 (2025).","journal-title":"Front. Immunol."},{"key":"1029_CR91","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri, M. A. Human natural killer cells. Blood 112, 461\u2013469 (2008).","journal-title":"Blood"},{"key":"1029_CR92","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12026-014-8493-4","volume":"58","author":"U Hadad","year":"2014","unstructured":"Hadad, U., Martinez, O. & Krams, S. M. NK cells after transplantation: friend or foe. Immunol. Res. 58, 259\u2013267 (2014).","journal-title":"Immunol. Res."},{"key":"1029_CR93","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1172\/JCI39922","volume":"120","author":"P Sagoo","year":"2010","unstructured":"Sagoo, P. et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J. Clin. Invest. 120, 1848\u20131861 (2010).","journal-title":"J. Clin. Invest."},{"key":"1029_CR94","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1615\/CritRevOncog.2014010827","volume":"19","author":"G Ferlazzo","year":"2014","unstructured":"Ferlazzo, G. & Moretta, L. Dendritic cell editing by natural killer cells. Crit. Rev. Oncog. 19, 67\u201375 (2014).","journal-title":"Crit. Rev. Oncog."},{"key":"1029_CR95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1084\/jem.20011149","volume":"195","author":"G Ferlazzo","year":"2002","unstructured":"Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343\u2013351 (2002).","journal-title":"J. Exp. Med."},{"key":"1029_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1294807","volume":"15","author":"D Lv","year":"2024","unstructured":"Lv, D. et al. Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury. Front. Immunol. 15, 1294807 (2024).","journal-title":"Front. Immunol."},{"key":"1029_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01484","volume":"11","author":"C Cantoni","year":"2020","unstructured":"Cantoni, C. et al. Recent advances in the role of natural killer cells in acute kidney injury. Front. Immunol. 11, 1484 (2020).","journal-title":"Front. Immunol."},{"key":"1029_CR98","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1152\/physiol.00046.2014","volume":"30","author":"Q Cao","year":"2015","unstructured":"Cao, Q., Harris, D. C. & Wang, Y. Macrophages in kidney injury, inflammation, and fibrosis. Physiology 30, 183\u2013194 (2015).","journal-title":"Physiology"},{"key":"1029_CR99","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.4049\/jimmunol.181.11.7489","volume":"181","author":"ZX Zhang","year":"2008","unstructured":"Zhang, Z. X. et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J. Immunol. 181, 7489\u20137498 (2008).","journal-title":"J. Immunol."},{"key":"1029_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90473-7","volume":"15","author":"R Sadler","year":"2025","unstructured":"Sadler, R. et al. The differential effect of Interferon-gamma on acute kidney injury and parasitemia in experimental malaria. Sci. Rep. 15, 6402 (2025).","journal-title":"Sci. Rep."},{"key":"1029_CR101","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","volume":"30","author":"JG Cyster","year":"2012","unstructured":"Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69\u201394 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"1029_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.647358","volume":"12","author":"MJ Shannon","year":"2021","unstructured":"Shannon, M. J. & Mace, E. M. Natural killer cell integrins and their functions in tissue residency. Front. Immunol. 12, 647358 (2021).","journal-title":"Front. Immunol."},{"key":"1029_CR103","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.4049\/jimmunol.1300358","volume":"191","author":"HJ Kim","year":"2013","unstructured":"Kim, H. J. et al. TLR2 signaling in tubular epithelial cells regulates NK cell recruitment in kidney ischemia-reperfusion injury. J. Immunol. 191, 2657\u20132664 (2013).","journal-title":"J. Immunol."},{"key":"1029_CR104","first-page":"E13","volume":"109","author":"HJ Kim","year":"2012","unstructured":"Kim, H. J. et al. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc. Natl Acad. Sci. USA 109, E13\u2013E22 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1029_CR105","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4049\/jimmunol.0903245","volume":"185","author":"ZX Zhang","year":"2010","unstructured":"Zhang, Z. X. et al. Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J. Immunol. 185, 967\u2013973 (2010).","journal-title":"J. Immunol."},{"key":"1029_CR106","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1089\/hum.2016.057","volume":"27","author":"X Zou","year":"2016","unstructured":"Zou, X. et al. NK cell regulatory property is involved in the protective role of MSC-derived extracellular vesicles in renal ischemic reperfusion injury. Hum. Gene Ther. 27, 926\u2013935 (2016).","journal-title":"Hum. Gene Ther."},{"key":"1029_CR107","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ckj\/sfac196","volume":"16","author":"I-W Wu","year":"2022","unstructured":"Wu, I.-W. et al. Deep immune profiling of patients with renal impairment unveils distinct immunotypes associated with disease severity. Clin. Kidney J. 16, 78\u201389 (2022).","journal-title":"Clin. Kidney J."},{"key":"1029_CR108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.34067\/KID.0000000000000305","volume":"5","author":"KG Burfeind","year":"2024","unstructured":"Burfeind, K. G., Funahashi, Y., Munhall, A. C., Eiwaz, M. & Hutchens, M. P. Natural killer lymphocytes mediate renal fibrosis due to acute cardiorenal syndrome. Kidney360 5, 8\u201321 (2024).","journal-title":"Kidney360"},{"key":"1029_CR109","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1681\/ASN.2017050479","volume":"29","author":"G Furini","year":"2018","unstructured":"Furini, G. et al. Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction. J. Am. Soc. Nephrol. 29, 880\u2013905 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR110","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1681\/ASN.2013050563","volume":"25","author":"A Scarpellini","year":"2014","unstructured":"Scarpellini, A. et al. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 25, 1013\u20131027 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59061175","volume":"59","author":"B Yadav","year":"2023","unstructured":"Yadav, B., Prasad, N., Agrawal, V., Agarwal, V. & Jain, M. Lower circulating cytotoxic T-cell frequency and higher intragraft granzyme-B expression are associated with inflammatory interstitial fibrosis and tubular atrophy in renal allograft recipients. Medicina\u00a059, 1175 (2023).","journal-title":"Medicina"},{"key":"1029_CR112","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/j.1523-1755.2004.00903.x","volume":"66","author":"AT Rowshani","year":"2004","unstructured":"Rowshani, A. T. et al. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection. Kidney Int. 66, 1417\u20131422 (2004).","journal-title":"Kidney Int."},{"key":"1029_CR113","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/cdd.2009.161","volume":"17","author":"JC Choy","year":"2010","unstructured":"Choy, J. C. Granzymes and perforin in solid organ transplant rejection. Cell Death Differ. 17, 567\u2013576 (2010).","journal-title":"Cell Death Differ."},{"key":"1029_CR114","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2222.2005.02238.x","volume":"35","author":"M Kuepper","year":"2005","unstructured":"Kuepper, M. et al. Increase in killer-specific secretory protein of 37 kDa in bronchoalveolar lavage fluid of allergen-challenged patients with atopic asthma. Clin. Exp. Allergy 35, 643\u2013649 (2005).","journal-title":"Clin. Exp. Allergy"},{"key":"1029_CR115","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.4049\/jimmunol.166.10.6404","volume":"166","author":"K Ogawa","year":"2001","unstructured":"Ogawa, K. et al. A novel serum protein that is selectively produced by cytotoxic lymphocytes. J. Immunol. 166, 6404\u20136412 (2001).","journal-title":"J. Immunol."},{"key":"1029_CR116","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd6832","volume":"5","author":"C Maucourant","year":"2020","unstructured":"Maucourant, C. et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci. Immunol. 5, eabd6832 (2020).","journal-title":"Sci. Immunol."},{"key":"1029_CR117","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1111\/ajt.17092","volume":"22","author":"PF Halloran","year":"2022","unstructured":"Halloran, P. F. et al. Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes. Am. J. Transpl. 22, 1976\u20131991 (2022).","journal-title":"Am. J. Transpl."},{"key":"1029_CR118","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/ajt.14600","volume":"18","author":"PF Halloran","year":"2018","unstructured":"Halloran, P. F. et al. Review: the transcripts associated with organ allograft rejection. Am. J. Transpl. 18, 785\u2013795 (2018).","journal-title":"Am. J. Transpl."},{"key":"1029_CR119","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","volume":"10","author":"LG Hidalgo","year":"2010","unstructured":"Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transpl. 10, 1812\u20131822 (2010).","journal-title":"Am. J. Transpl."},{"key":"1029_CR120","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.bbadis.2018.06.009","volume":"1864","author":"T Taetzsch","year":"2018","unstructured":"Taetzsch, T., Brayman, V. L. & Valdez, G. FGF binding proteins (FGFBPs): modulators of FGF signaling in the developing, adult, and stressed nervous system. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2983\u20132991 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1029_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie, Y. et al. FGF\/FGFR signaling in health and disease. Signal Transduct. Target. Ther. 5, 181 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1029_CR122","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1083\/jcb.128.6.1221","volume":"128","author":"A Hanneken","year":"1995","unstructured":"Hanneken, A., Maher, P. A. & Baird, A. High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells \u2014 implications for the modulation of FGF-2. J. Cell Biol. 128, 1221\u20131228 (1995).","journal-title":"J. Cell Biol."},{"key":"1029_CR123","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1073\/pnas.97.1.49","volume":"97","author":"DJ Stauber","year":"2000","unstructured":"Stauber, D. J., DiGabriele, A. D. & Hendrickson, W. A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl Acad. Sci. USA 97, 49\u201354 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1029_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100009","volume":"103","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Fibroblast growth factor 2 Is produced by renal tubular cells to act as a paracrine factor in maladaptive kidney repair after cisplatin nephrotoxicity. Lab. Invest. 103, 100009 (2023).","journal-title":"Lab. Invest."},{"key":"1029_CR125","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1080\/15548627.2023.2281156","volume":"20","author":"MJ Livingston","year":"2024","unstructured":"Livingston, M. J. et al. Autophagy activates EGR1 via MAPK\/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair. Autophagy 20, 1032\u20131053 (2024).","journal-title":"Autophagy"},{"key":"1029_CR126","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6371","volume":"383","author":"S Aggarwal","year":"2024","unstructured":"Aggarwal, S. et al. SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys. Science 383, eadd6371 (2024).","journal-title":"Science"},{"key":"1029_CR127","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1189\/jlb.71.2.173","volume":"71","author":"MJ Robertson","year":"2002","unstructured":"Robertson, M. J. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71, 173\u2013183 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"1029_CR128","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","volume":"23","author":"HJ Anders","year":"2023","unstructured":"Anders, H. J., Kitching, A. R., Leung, N. & Romagnani, P. Glomerulonephritis: immunopathogenesis and immunotherapy. Nat. Rev. Immunol. 23, 453\u2013471 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1029_CR129","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1126\/science.8066448","volume":"265","author":"DL Sylvestre","year":"1994","unstructured":"Sylvestre, D. L. & Ravetch, J. V. Fc receptors initiate the arthus reaction: redefining the inflammatory cascade. Science 265, 1095\u20131098 (1994).","journal-title":"Science"},{"key":"1029_CR130","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1189\/jlb.4A0714-326R","volume":"97","author":"R Spada","year":"2015","unstructured":"Spada, R. et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J. Leukoc. Biol. 97, 583\u2013598 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"1029_CR131","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","volume":"24","author":"M Naesens","year":"2024","unstructured":"Naesens, M. et al. The Banff 2022 Kidney Meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am. J. Transpl. 24, 338\u2013349 (2024).","journal-title":"Am. J. Transpl."},{"key":"1029_CR132","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S0140-6736(18)32473-5","volume":"393","author":"R Reindl-Schwaighofer","year":"2019","unstructured":"Reindl-Schwaighofer, R. et al. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort. Lancet 393, 910\u2013917 (2019).","journal-title":"Lancet"},{"key":"1029_CR133","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJMoa2408835","volume":"392","author":"M Sablik","year":"2025","unstructured":"Sablik, M. et al. Microvascular inflammation of kidney allografts and clinical outcomes. N. Engl. J. Med. 392, 763\u2013776 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1029_CR134","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","volume":"12","author":"T Hirohashi","year":"2012","unstructured":"Hirohashi, T. et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am. J. Transpl. 12, 313\u2013321 (2012).","journal-title":"Am. J. Transpl."},{"key":"1029_CR135","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.kint.2016.02.030","volume":"89","author":"N Kohei","year":"2016","unstructured":"Kohei, N. et al. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts. Kidney Int. 89, 1293\u20131306 (2016).","journal-title":"Kidney Int."},{"key":"1029_CR136","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.kint.2018.08.041","volume":"95","author":"T Yagisawa","year":"2019","unstructured":"Yagisawa, T. et al. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection. Kidney Int. 95, 350\u2013362 (2019).","journal-title":"Kidney Int."},{"key":"1029_CR137","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148747","volume":"6","author":"S Miyairi","year":"2021","unstructured":"Miyairi, S. et al. Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection. JCI Insight 6, e148747 (2021).","journal-title":"JCI Insight"},{"key":"1029_CR138","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","volume":"95","author":"S Yazdani","year":"2019","unstructured":"Yazdani, S. et al. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. Kidney Int. 95, 188\u2013198 (2019).","journal-title":"Kidney Int."},{"key":"1029_CR139","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1681\/ASN.2007010073","volume":"18","author":"RB Colvin","year":"2007","unstructured":"Colvin, R. B. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J. Am. Soc. Nephrol. 18, 1046\u20131056 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR140","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1681\/ASN.V123574","volume":"12","author":"S Mauiyyedi","year":"2001","unstructured":"Mauiyyedi, S. et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J. Am. Soc. Nephrol. 12, 574\u2013582 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39859-7","volume":"14","author":"B Lamarthee","year":"2023","unstructured":"Lamarthee, B. et al. Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. Nat. Commun. 14, 4359 (2023).","journal-title":"Nat. Commun."},{"key":"1029_CR142","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.kint.2023.04.024","volume":"104","author":"E Bailly","year":"2023","unstructured":"Bailly, E. et al. Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity. Kidney Int. 104, 707\u2013723 (2023).","journal-title":"Kidney Int."},{"key":"1029_CR143","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/ki.1995.194","volume":"47","author":"PA Hill","year":"1995","unstructured":"Hill, P. A., Main, I. W. & Atkins, R. C. ICAM-1 and VCAM-1 in human renal allograft rejection. Kidney Int. 47, 1383\u20131391 (1995).","journal-title":"Kidney Int."},{"key":"1029_CR144","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.ajt.2025.04.024","volume":"25","author":"E Alari-Pahissa","year":"2025","unstructured":"Alari-Pahissa, E. et al. Alloreactive adaptive natural killer cells in renal transplantation: potential contribution to allograft microvascular inflammation. Am. J. Transpl. 25, 1657\u20131669 (2025).","journal-title":"Am. J. Transpl."},{"key":"1029_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13209","volume":"37","author":"M Diebold","year":"2024","unstructured":"Diebold, M. et al. Natural killer cell presence in antibody-mediated rejection. Transpl. Int. 37, 13209 (2024).","journal-title":"Transpl. Int."},{"key":"1029_CR146","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.celrep.2016.04.005","volume":"15","author":"LL Liu","year":"2016","unstructured":"Liu, L. L. et al. Critical Role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans. Cell Rep. 15, 1088\u20131099 (2016).","journal-title":"Cell Rep."},{"key":"1029_CR147","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","volume":"24","author":"M Diebold","year":"2024","unstructured":"Diebold, M. et al. Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation. Am. J. Transpl. 24, 743\u2013754 (2024).","journal-title":"Am. J. Transpl."},{"key":"1029_CR148","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4049\/jimmunol.1601236","volume":"198","author":"D Redondo-Pachon","year":"2017","unstructured":"Redondo-Pachon, D. et al. Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients. J. Immunol. 198, 94\u2013101 (2017).","journal-title":"J. Immunol."},{"key":"1029_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041088","volume":"9","author":"L Llinas-Mallol","year":"2020","unstructured":"Llinas-Mallol, L. et al. Long-term redistribution of peripheral lymphocyte subpopulations after switching from calcineurin to mTOR inhibitors in kidney transplant recipients. J. Clin. Med. 9, 1088 (2020).","journal-title":"J. Clin. Med."},{"key":"1029_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132484","volume":"10","author":"U Hoffmann","year":"2015","unstructured":"Hoffmann, U. et al. NK Cells of kidney transplant recipients display an activated phenotype that is influenced by immunosuppression and pathological staging. PLoS ONE 10, e0132484 (2015).","journal-title":"PLoS ONE"},{"key":"1029_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00046","volume":"4","author":"C Neudoerfl","year":"2013","unstructured":"Neudoerfl, C. et al. The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs. Front. Immunol. 4, 46 (2013).","journal-title":"Front. Immunol."},{"key":"1029_CR152","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ajt.2024.09.018","volume":"25","author":"E Bailly","year":"2025","unstructured":"Bailly, E. et al. FCGR2C Q13 and FCGR3A V176 alleles jointly associate with worse natural killer cell-mediated antibody-dependent cellular cytotoxicity and microvascular inflammation in kidney allograft antibody-mediated rejection. Am. J. Transpl. 25, 302\u2013315 (2025).","journal-title":"Am. J. Transpl."},{"key":"1029_CR153","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","volume":"31","author":"M Diebold","year":"2025","unstructured":"Diebold, M. et al. Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies. Nat. Med. 31, 1668\u20131676 (2025).","journal-title":"Nat. Med."},{"key":"1029_CR154","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1111\/ajt.15364","volume":"19","author":"WH Marks","year":"2019","unstructured":"Marks, W. H. et al. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial. Am. J. Transpl. 19, 2876\u20132888 (2019).","journal-title":"Am. J. Transpl."},{"key":"1029_CR155","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.ackd.2019.12.002","volume":"27","author":"A Bhalla","year":"2020","unstructured":"Bhalla, A., Alachkar, N. & Alasfar, S. Complement-based therapy in the management of antibody-mediated rejection. Adv. Chronic Kidney Dis. 27, 138\u2013148 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"1029_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845301","volume":"13","author":"G Tiller","year":"2022","unstructured":"Tiller, G. et al. Weak expression of terminal complement in active antibody-mediated rejection of the kidney. Front. Immunol. 13, 845301 (2022).","journal-title":"Front. Immunol."},{"key":"1029_CR157","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-024-02972-1","volume":"30","author":"E Schmauch","year":"2024","unstructured":"Schmauch, E. et al. Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat. Med. 30, 1448\u20131460 (2024).","journal-title":"Nat. Med."},{"key":"1029_CR158","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S0140-6736(23)01349-1","volume":"402","author":"A Loupy","year":"2023","unstructured":"Loupy, A. et al. Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study. Lancet 402, 1158\u20131169 (2023).","journal-title":"Lancet"},{"key":"1029_CR159","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.transproceed.2005.01.052","volume":"37","author":"S Uehara","year":"2005","unstructured":"Uehara, S., Chase, C. M., Colvin, R. B., Russell, P. S. & Madsen, J. C. Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy. Transpl. Proc. 37, 70\u201371 (2005).","journal-title":"Transpl. Proc."},{"key":"1029_CR160","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.4049\/jimmunol.175.5.3424","volume":"175","author":"S Uehara","year":"2005","unstructured":"Uehara, S. et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J. Immunol. 175, 3424\u20133430 (2005).","journal-title":"J. Immunol."},{"key":"1029_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13113-5","volume":"10","author":"A Koenig","year":"2019","unstructured":"Koenig, A. et al. Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants. Nat. Commun. 10, 5350 (2019).","journal-title":"Nat. Commun."},{"key":"1029_CR162","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1681\/ASN.2020111558","volume":"32","author":"J Callemeyn","year":"2021","unstructured":"Callemeyn, J. et al. Missing self-induced microvascular rejection of kidney allografts: a population-based study. J. Am. Soc. Nephrol. 32, 2070\u20132082 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR163","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1681\/ASN.2020030306","volume":"31","author":"J Callemeyn","year":"2020","unstructured":"Callemeyn, J. et al. Transcriptional changes in kidney allografts with histology of antibody-mediated rejection without anti-HLA donor-specific antibodies. J. Am. Soc. Nephrol. 31, 2168\u20132183 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR164","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/TP.0000000000005228","volume":"109","author":"M Diebold","year":"2025","unstructured":"Diebold, M. et al. Functional natural killer-cell genetics and microvascular inflammation after kidney transplantation: an observational cohort study. Transplantation 109, 860\u2013870 (2025).","journal-title":"Transplantation"},{"key":"1029_CR165","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1681\/ASN.2020040433","volume":"32","author":"A Koenig","year":"2021","unstructured":"Koenig, A. et al. Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection. J. Am. Soc. Nephrol. 32, 479\u2013494 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1029_CR166","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.ajt.2025.03.031","volume":"25","author":"GA Bohmig","year":"2025","unstructured":"Bohmig, G. A., Loupy, A., Sablik, M. & Naesens, M. Microvascular inflammation in kidney allografts: new directions for patient management. Am. J. Transpl. 25, 1410\u20131416 (2025).","journal-title":"Am. J. Transpl."},{"key":"1029_CR167","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.185687","volume":"9","author":"DF Ruan","year":"2024","unstructured":"Ruan, D. F. et al. High-dimensional analysis of NK cells in kidney transplantation uncovers subsets associated with antibody-independent graft dysfunction. JCI Insight\u00a09, e185687 (2024).","journal-title":"JCI Insight"},{"key":"1029_CR168","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1111\/ajt.16690","volume":"21","author":"CM Lin","year":"2021","unstructured":"Lin, C. M., Gill, R. G. & Mehrad, B. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation. Am. J. Transpl. 21, 3550\u20133560 (2021).","journal-title":"Am. J. Transpl."},{"key":"1029_CR169","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/87880","volume":"7","author":"S Maier","year":"2001","unstructured":"Maier, S. et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28\u2212\/\u2212 mice. Nat. Med. 7, 557\u2013562 (2001).","journal-title":"Nat. Med."},{"key":"1029_CR170","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/TP.0000000000005187","volume":"109","author":"M Diebold","year":"2025","unstructured":"Diebold, M. et al. Chronic rejection after kidney transplantation. Transplantation 109, 610\u2013621 (2025).","journal-title":"Transplantation"},{"key":"1029_CR171","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa2400763","volume":"391","author":"KA Mayer","year":"2024","unstructured":"Mayer, K. A. et al. A randomized phase 2 trial of felzartamab in antibody-mediated rejection. N. Engl. J. Med. 391, 122\u2013132 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1029_CR172","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/TP.0b013e3181d05a58","volume":"89","author":"S Haustein","year":"2010","unstructured":"Haustein, S. et al. Interleukin-15 receptor blockade in non-human primate kidney transplantation. Transplantation 89, 937\u2013944 (2010).","journal-title":"Transplantation"},{"key":"1029_CR173","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/01.TP.0000438636.52085.50","volume":"97","author":"BH Shin","year":"2014","unstructured":"Shin, B. H. et al. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. Transplantation 97, 294\u2013300 (2014).","journal-title":"Transplantation"},{"key":"1029_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02279","volume":"10","author":"MI Ashraf","year":"2019","unstructured":"Ashraf, M. I. et al. Natural killer cells promote kidney graft rejection independently of cyclosporine A therapy. Front. Immunol. 10, 2279 (2019).","journal-title":"Front. Immunol."},{"key":"1029_CR175","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nri1863","volume":"6","author":"DH Raulet","year":"2006","unstructured":"Raulet, D. H. & Vance, R. E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6, 520\u2013531 (2006).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01029-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01029-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01029-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:02:19Z","timestamp":1771592539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01029-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-01029-x","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"22 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}